Millions of GM mosquitoes released by the Bill and Melinda
Gates Foundation are creating mutations that cause deadly resistant
vector-borne diseases in humans, according to a new report.
The World Mosquito Program,
funded by the Bill and Melinda Gates Foundation, is a radical operation
that claims to want to eradicate mosquito-borne diseases such as
dengue, Zika, yellow fever and chikungunya.
Naturalnews.com
reports: The global operation has projects in 14 countries and claims
to have protected 11 million people from vector borne diseases over the
past decade. These projects include the release of billions of
genetically modified mosquitoes.
To start, the mosquito eggs are injected with Wolbachia bacteria.
After they are released, they are counted on to mate with the
indigenous population of mosquitoes and eradicate the species that
spread diseases like dengue, chikungunya, Zika virus and yellow fever.
“We actually grow these mosquitoes that contain the bacteria, Wolbachia, and then release them into communities where the bacteria Wolbachia spreads into the wild mosquito population,” said Scott O’Neill, a micro-biologist at Monash University in Melbourne, Australia, and director of the World Mosquito Program.
Mass mosquito experiments do not account for selective pressure and resistant traits in mosquitoes and pathogens
But the program did not account for the emergence of resistant traits in mosquitoes or target pathogens. There is evidence that transgenic Aedes aegypti mosquitoes
transfer genes into a natural population. What pressures does that
create on the mosquito population and the pathogens they carry? The
influx of Wolbachia bacteria into the mosquito population can
put selective pressure on the genomes of the mosquitoes and the viruses
that the mosquitoes transmit, encouraging the development of new, resistant pathogenic species and strains.
This biological fallout is similar to the emergence of
antibiotic-resistant bacteria due to the selective pressure of
antibiotics on specific traits of pathogens.
The genetically modified mosquitoes do not eradicate the vector-borne diseases with perfection and certainty. Mutations have been documented in
genetically engineered lethality systems that were intended to control
mosquito populations. In one study, researchers found that a release of
mosquitoes carrying a dominant lethal gene causes a toxic
over-expression that leads to resistance in certain mosquito
populations. In laboratory studies, they found that the
disease-carrying A. aegypti mosquitoes resisted and retained
3.5% of their populations. The scientists concurred that this is due
“primarily, to inherent “leakiness” in the respective systems due to
variable transgenic lethal effector expression or function, though
heritable survival due to mutations in genetic components of the system
[that] have yet to be reported.”
The researchers also said that there is “potential for the genetic
breakdown of lethality systems by rare spontaneous mutations, or
selection for inherent suppressors.”
These mutations may cause resistant vector-borne diseases that are
even harder to eradicate and/or treat once they infect humans.
Gates Foundation to erect a mosquito breeding factory in Brazil and capitalize on dengue vaccine experiments
The Gates Foundation is taking their “philanthropy” back to the streets of Brazil. The Gates Foundation is committing $55 million on an experimental Dengue vaccine and
are funding the development of a mosquito breeding factory that will
release 5 billion genetically modified mosquitoes per year.
When the World Mosquito Program first launched in Brazil in 2011, their pilot studies showed that Wolachia does decrease the risk of Aedes aegypti mosquitoes
transmitting viruses. While this may help mitigate vector borne
diseases in the short term, it could lead to the resurgence of more
resistant diseases.
The first live mosquito experiment in Brazil occurred in September of 2014 in Rio de Janeiro.
By 2017, full scale experiments were being conducted with the help of
the Oswaldo Cruz Foundation (Fiocruz), under the guidance of the
Ministry of Health. Ten years later, the results of this experiment have
been abysmal. Today, there are more than 2.8 million cases of dengue
fever reported in the Americas. Of those countries, Brazil reported the second highest number of cases, with 1,104.5 cases per 100,000 people. In the first five weeks of 2024,
there have been 364,855 reported cases of dengue infection, an
incidence of disease four times greater than the same period in 2023.”
Bloomberg and other bought-out media outlets are claiming “global warming” is causing the uptick in dengue.
They make these claims without any investigation into the environmental
and genetic drivers of this vector-borne disease phenomenon in Brazil.
There is no mention of the potential fallout of mosquito experiments in
the country.
Not surprisingly, Brazil’s Ministry of Health approved a new dengue vaccine in 2023,
and became the first country in the world to offer the experimental
injection through their public health system. The Gates Foundation,
which funded the mass mosquito experiments, is behind this mass
vaccination effort, too, and looks to capitalize on the ongoing failures of their mass mosquito experiment.
Click this link for the original source of this article.
Author: Planet Today
This content is courtesy of, and owned and copyrighted by, https://www.planet-today.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.